Global Respiratory Drugs and Devices Market Research and Analysis

Global Respiratory Drugs and Devices Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2014-2020

RESPIRATORY DRUGS AND DEVICES MARKET INSIGHT:

Global respiratory drugs and devices market is expected to grow at a CAGR of 7.8% for the forecasted period of 2016-2021. Respiratory drugs market has 65% market share compared to 35% market share of respiratory devices market. The market is driven by growing prevalence of respiratory diseases and disorders. There is been constant growth in the number of cases asthma and COPD.  Asthma and COPD account for approximately 60% of the respiratory drugs and devices market. An aging population and major lifestyle changes have led to rise in respiratory diseases. Habits such as overeating, smoking, lack of exercise and other major lifestyle changes are causing respiratory diseases. Cases of the respiratory disorder are also on a rise in newborn.

Respiratory drugs and devices companies are concentrating on developing new products. Companies are expanding their product portfolios and increasing their R&D budget. Major respiratory devices include therapeutic devices such as masks, ventilators, humidifiers, positive airway pressure devices and other devices. Other respiratory devices include diagnostic and monitoring devices and consumables and accessories meters.  Respiratory drugs segmented on the basis of route of administration and drugs class.

North America is the leading market. The market is expected to grow at a stable CAGR. North American market is driven by high sales of branded drugs and a high number of patient diagnosed and treated for respiratory diseases. North American marker is followed by Europe, Asia Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR amongst all regions for the forecasted period of 2016-2021. APAC market is driven by growing aging population with respiratory disorders. Pollution and lifestyle changes are also driving the APAC market.

THE REPORT COVERS:

• Comprehensive research methodology of respiratory drugs and devices market.
• In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global respiratory drugs and devices market.
• Insights about market determinants which are stimulating the global respiratory drugs and devices market.
• Detailed and extensive market segments with regional distribution of forecasted revenues
• Extensive profiles and recent developments of market players

Market Segmentation Included:

1. Global Respiratory Drugs and Devices Market
   • Global Respiratory Devices by Product Market
     • Global Respiratory Therapeutic Devices Market
     • Global Respiratory Diagnostic and Monitoring Devices Market
     • Global Respiratory Consumables and Accessories Meters Market
   • Global Respiratory Drugs Market
     • Global Respiratory Drugs by Route of Administration Market
     • Global Respiratory Drugs by Drug Class Market

2. Global Respiratory Drugs and Devices Market by End Users Market

COMPANIES PROFILED IN THE REPORT:

1. Philips Healthcare
2. Novartis
3. GlaxoSmithKline
4. AstraZeneca
5. Covidien Plc
6. Roche
7. Baxter International
8. Ge Healthcare Limited
9. Air Liquide S.A.
10. Otsuka Pharmaceuticals
11. Pfizer
12. Merck And Co.
13. Boehringer Ingelheim
14. Teva Pharmaceuticals
15. Compumedics Limited
16. Fisher And Paykel Healthcare Corp. Ltd
17. Chart Industries
18. Invacare Corporation
19. Drager Medical GmBH
20. Hamilton Medical Ag